Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Home
Clinical development
Phase III
Phase III
Phase III
Long-term Outcomes of Radiation Techniques for the Treatment of Locally Advanced NSCLC
Peter Hofland
-
September 12, 2023
Reducing Reliance on Blood Transfusions for People With Lower-risk Myelodysplastic Syndromes
Dostarlimab + Chemotherapy Accepted for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer
Radiation after Chemoimmunotherapy for Primary Mediastinal B-cell Lymphoma may Not be Necessary
Ciltacabtagene Autoleucel Reduces Risk of Progression of Multiple Myeloma after Lenalidomide
Trastuzumab Deruxtecan Is an Effective Option for Difficult-to-treat HER2-expressing Solid Tumors
Editorial Team
-
June 5, 2023
Mirvetuximab Soravtansine Improves Survival in Women With Recurrent Ovarian Cancer
Editorial Team
-
June 4, 2023
Study Shows Nivolumab Reduces Risk of Disease Progression in Advanced, Untreated Hodgkin Lymphoma
Editorial Team
-
June 4, 2023
Adjuvant Osimertinib Significantly Improves Survival in Patients With Resected EGFR-Mutated NSCLC
Editorial Team
-
June 4, 2023
Radiation Can Be Safely Omitted in Select Patients With Locally Advanced Rectal Cancer
Editorial Team
-
June 4, 2023
Vorasidenib Significantly Improves Progression-free Survival in Grade 2 Glioma with IDH Mutation
Editorial Team
-
June 4, 2023
Combination of Olaparib + Durvalumab Prolonged Progression-Free Survival in Advanced Ovarian Cancer
Editorial Team
-
June 3, 2023
Ribociclib Added to Hormonal Therapy Helps Reduce Risk of Recurrence of a Subtype of...
Editorial Team
-
June 2, 2023
What to expect at ASCO ’23: Lilly’s Progress in Treatment of Breast Cancer and...
Editorial Team
-
June 2, 2023
MIRASOL Trial: Elahere® Shows Survival Benefit in FRα-Positive Platinum-Resistant Ovarian Cancer
Editorial Team
-
May 4, 2023
1
2
3
...
9
Page 1 of 9
LATEST NEWS
October Breast Cancer Awareness Month: Emphasizing Equity in Access to Early Detection
Danielle Garcia
-
September 20, 2023
Breaking Barriers to Access: Empowering Vulnerable Populations with Cell and Gene Therapy
Jennifer Klarer
-
September 18, 2023
Understanding the True Impact of Microbiota on Cancer Development and Treatment
Peter Hofland
-
September 18, 2023
Language Barriers and the Impact on Cancer Care
Peter Hofland
-
September 16, 2023
Long-term Outcomes of Radiation Techniques for the Treatment of Locally Advanced NSCLC
Peter Hofland
-
September 12, 2023
X